Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

A Study to Evaluate the Effect of Lorcaserin Hydrochloride on Smoking Cessation

ClinicalTrials.gov ID: NCT02044874

Public ClinicalTrials.gov record NCT02044874. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 7:04 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A 12-Week, Multicenter, Double-blind, Randomized, Placebo-controlled Parallel-group Phase 2 Dose Selection Study of Lorcaserin Hydrochloride, an Oral 5-HT2C Receptor Agonist for Smoking Cessation

Study identification

NCT ID
NCT02044874
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Arena Pharmaceuticals
Industry
Enrollment
603 participants

Conditions and interventions

Interventions

  • APD356-lorcaserin hydrochloride Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 28, 2014
Primary completion
Oct 31, 2014
Completion
Oct 31, 2014
Last update posted
Apr 15, 2019

2014

United States locations

U.S. sites
31
U.S. states
14
U.S. cities
30
Facility City State ZIP Site status
Pharmacology Research Institute Encino California 91316
Synergy Escondido Escondido California 92025
Pharmacology Research Institute Los Alamitos California 90720
Pharmacology Research Institute Newport Beach California 92660
Desert Valley Research Rancho Mirage California 92270
Avail Clinical Research DeLand Florida 32720
Clinical Neuroscience Solutions, Inc. Jacksonville Florida 32256
Meridien Research Lakeland Florida 33805
Compass Research East Leesburg Florida 34748
Clinical Neuroscience Solutions, Inc. Orlando Florida 32806
Compass Research Orlando Florida 32806
Compass Research East Oviedo Florida 32765
Meridien Research Tampa Florida 33606
iResearch Atlanta Decatur Georgia 30030
Center for Pharmaceutical Research Kansas City Missouri 64114
Quality Clinical Research Inc. Omaha Nebraska 68114
Clinical Research Center of Nevada Las Vegas Nevada 89104
Integrative Clinical Trials Brooklyn New York 11229
Duke University Durham North Carolina 27705
PMG Research Inc. Raleigh North Carolina 27609
PMG Research Inc. Wilmington North Carolina 28401
PMG Research Inc. Winston-Salem North Carolina 27103
Neurobehavioral Clinical Research Canton Ohio 44718
Midwest Clinical Research Center Dayton Ohio 45417
Clinical Trial Center Jenkintown Pennsylvania 19046
Lincoln Research Lincoln Rhode Island 02865
Coastal Carolina Research Center Mt. Pleasant South Carolina 29464
Clinical Neuroscience Solutions, Inc. Memphis Tennessee 38119
Clinical Research Associates, Inc. Nashville Tennessee 37203
Benchmark Research Austin Texas 78705
KRK Medical Research Dallas Texas 75230

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02044874, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 15, 2019 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02044874 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →